Queen Mary Hospital ( Site 3100)

Hong Kong 000000

1 studies enrolling now · 2 studies all time

What they study most

DLBCL, Diffuse Large B-Cell Lymphoma, Gastroesophageal Cancer

Studies at this site

• A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003) — Recruiting now
• A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) — Running, not enrolling